Index
Vaccine trials successful in treating poultry against coccidiosis
// 19 May 2008
Imugene Ltd reports that the Imugene/Abic vaccine induced protection
against the major poultry disease coccidiosis in trials conducted by Abic
Biological Laboratories Teva Ltd in conjunction with the University of
Technology Sydney.
The Business Spectator reports that the vaccine candidate groups that
produced the most protection were orally vaccinated at 1 day old and day
14.
The next stages in the development of the vaccine will require trialling to
determine a minimum dose and an optimum date of administration for
protection.
Imugene MD, Warwick lamb: "The vaccine has surpassed the accepted
commercial parameters for protection against this disease."
Imugene says that coccidiosis is one of the most common and costly diseases
in poultry, causing weight loss and poor feed conversion, and in severe case,
mortality.
Related links:
Mail a friend
Print
